Home » Salveo Capital

Salveo Capital

KelSie Biotech Closes First Tranche of $5 Million Series A Round to expand its Unique Drug Delivery Intellectual Property Portfolio and Expand Market Penetration

BOULDER, CO - May 31, 2019 /AxisWire/ KelSie Biotech, announced today that it has closed the first tranche of $5 million in Series A funding.

Top